Back
Svenska Handelsbanken AB Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
43
SVNLY
Svenska Handelsbanken AB
Last Price:
$6.48
Seasonality Move:
-5.47%
Buy
61
ALNY
Alnylam Pharmaceuticals
Last Price:
$290.61
Seasonality Move:
3.3%
Sell
43
Svenska Handelsbanken AB (SVNLY)
is a Sell
Is Svenska Handelsbanken AB a Buy, Sell or Hold?
-
The current Svenska Handelsbanken AB [SVNLY] share price is $6.47. The Score for SVNLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SVNLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SVNLY Stock Price Chart
What is Svenska Handelsbanken AB's stock price today?
-
The Svenska Handelsbanken AB share price today is $6.47The current trend is moderately bullish and SVNLY is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $283.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SVNLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 57.94 | Buy |
Chaikin Money Flow: | 6141 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.12 - 6.56) | Buy |
Bollinger Bands (100): | (5 - 6.04) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 68.89 | Buy |
Chaikin Money Flow: | 1798941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.98 - 259.48) | Buy |
Bollinger Bands (100): | (240.26 - 271.94) | Buy |
SVNLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.49 | Sell |
20-day SMA: | 6.43 | Buy |
50-day SMA: | 5.91 | Buy |
200-day SMA: | 5.21 | Buy |
8-day EMA: | 6.49 | Sell |
20-day EMA: | 6.37 | Buy |
50-day EMA: | 6.01 | Buy |
200-day EMA: | 5.38 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 251.71 | Buy |
20-day SMA: | 247.77 | Buy |
50-day SMA: | 256.39 | Buy |
200-day SMA: | 250.79 | Buy |
8-day EMA: | 256.23 | Buy |
20-day EMA: | 252.43 | Buy |
50-day EMA: | 253.95 | Buy |
200-day EMA: | 242.96 | Buy |
Svenska Handelsbanken AB Earnings Growth & SVNLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.
Svenska Handelsbanken AB Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |